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FREQUENCY OF FAB SUBTYPES IN ACUTE MYELOID LEUKE:\11A 
PATIENTS AT AGA KHAN UNIVERSITY HOSPITAL KARACHI 
Mahadev S. Harani, Salman Naseem Adil, Mohammad l!sman Shaikh, 
Ghulam Nabi Kakepoto, Mohammmad Khurshid, 
lkpartmcnl Of P~1tholo11,y & :\licrollinlogy, .-\.ga 1\.h:tn L'ni\CL\il~. h.<tr~rchi 
Background: Acute myeloid leukemia (/\fv·IL) is a heterogeneous di~ca-;c. Then:fmc, vannus 
parnmctcrs are needed to classify this disease into .-;ubtypcs, so that spcci1ic tn.·atlllcnt approaches 
can be utilized effcctiH~Iy. The commonly used methud for diagnosi.c; and classification is based 
on fAR criteria using morphology and cytochemical st<lins. For .c;omc or the categories, 
imllll!llOphcnotyping is llCCCSS<lry. The aim of present study is to determine the llTqucncy or 
various sub typ.:s in acute myeloid lcukcr11i<:l using Fr\11 criteria in our popul:1tion. Thi~ \\ il! aid in 
the COrrect diagnosiS Of '-!CUte k·ukt:ll1ia and hellCl' proper lllilllagC!l1l'!lt or !ilL' p:llit:llh. i\lateriab 
and \lrthuds: This is dc~cripti\'e case control :>tudy concluctcd at :\ga Khan Lni\·u·.;ity llnspital 
from January 1999 to DcccmbL'r 2000. The tnt<~! number of subject;, \\'ilS II() that included both 
adults and children. The patienis were diugnnsed on the basis or bone m:1rrow morphology using 
rAB cbssification. Cytochemistry was done in all cases, while immunophcnotyping \\·as 
considered only in tho~l' case~ that were fouml to be problematic. Results: Among 110 patients. 
70 \\ crL' males and 46 \\ere females \\ ith male tn fclllale ratio 1.5: I. ['he age ranged between 6 
months to S.5 ye~1rs with a mean age or 32 ycms . .-\ML-M4 was the prL·dominant r:rcnch-
t\nlL'ric:ul-British (FA]{) subt.ype {:-;6 . .2 1:/;1) followed by J\.1.2 (:l0 . .2Y;<1). J\.1) { l 0.4°/;i). !'vii (S.7'>(1). :-...w 
(7 7" o), !viSa (3.5°--(i), i\·15b (.2S~--o) <lnd \16 (O.S 01(1). Conclusions: The 1110'-;t C0111lllO!l J.".,\B suhtypL' 
ob.-.,crvcd in our .study was !\cute myelon10nocytic leukemia {M4) which i~ in accordance \\ith 
studies reported Jl·om Snudia Arabia and a previous study reported from our Institution. 
However,othcr ll<ltional and international studies have reported Myelobl;tstic Leukemia \\·ith 
matur<ltion ( M:2) as the prl'dominant subtyp: of AML. 
Kcy,,ords: Frcnch-,\merican-British (1-"l\B) cla . .,sification. Acute myL·Ioid Leukemic! (AML). 
subtypes. 
INTRODLCTIOI\" 
Acute myeloid Lcukemi<l is a heterogeneous disease. 
Thercrore parameters arc needed to cb . ..,sify thi;, 
disease into hio!ogic entities to understand its 
pclthogencsis and dcYelop spcciftc treatment 
approaches.~_ ·' :\s therapeutic <ldvanccs \\'Cre made, 
distinguishing the subtypes of acute leukemia became 
inen.:asingly in1portant. 
.Acute leukemias are cbs . ..,i!icd on the basis 
of the presumed cell of origin. Concordance between 
experienced observers in the classification or acute 
leukemia mcreases from 70 to 99<;~1 when 
morphologic criteria are supplemented by 
cytochemical and immunphenotypic information.-' 
The modern era for clas~irication or acute 
leukemias dme.'-' back to !976. when intcrnation~J! 
group of investigators from France, America and 
Britain dcv eloped a uniform c lassitlcation system 
designated as French-American-British (FAB) 
clas~ification-1, which was subsequently revised in 
!9R5.' 
The FJ\B classification of J\ML di\ ides 
cases into eight major groups with subtyTJCs ror three 
of them (table I). The classification criteria arc based 
011 morrhologic and cytochemical feawrcs: hovvever 
for .',OillC or the Categories, illllllH!lOp!lellOtyping is 
ntcessary.(,, 7 It is lineage-based morphological 
classi !lcation that categorizes cases according to the 
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degree or matllration of the leukemic cell." and their 
lineage diffl:rcntiation. The major ad\·antagc of the 
FAB cb~sifieation :-.ystem is its case of usc. The 
cytological criteria arc \vcll defined: they· do not 
require high technology and Cdll be appliec1 in 1110:-:,t 
htboratories through out the \\Orld "Keeping i11 \ ie\' 
these ad\'antagcs, the FAB proposal \\·as ~nlopkd 
intcrnmion<llly. It pro\ !lied long needed ..,umcbrd 
terminology and wa:-, qurckly acccrted by most of the 
multi-institutional stu<l~ groups for llldll<lgemcnt 
[llans and CO!llp<.trison of treatment results het\\'l"Cll 
morphologic subtypes for their prog:nostil.' 
significance. 
Present study was done to determine the 
frequency of AML tyres in our populatio11 . .-\c; the 
patients were tl·om all over Pakist<m bclong1n); to 
various ethnic groups, our study thus well repn:~cnt 
AML subtypes of the entire country. 
Altllough. it is a single institution based 
study, the number of cases studied is largest that i..; 
ever reported at national level. Hence. our '::itudy 
tends to establish <1 trend or J\ML subtypes in 
Pakistan. 
MATERIAL AND METHODS 
This is descriptive case-control study done at 
hematology department of Agc1 Khan University 
Hospital. This is <1 tertiary care hospital receiving 
c<tc-e:-; from all over 1hc country. The study was 
cnnduc!ed oYer a period of 2 years from January 
19_99 to 1 kccmbcr 2000. 
Patients \\"ith history of pre\"lous 
hcmatnlogictl disorders like myelodysplasia, CML. 
;Jpb.c;tic anaemia and \\·ith hi.c;tory prior chemotherapy 
ur r<ldiothL·rapy \\t.:'rc cxcludL·d from the :-.tudy. The 
p;tticnts who were knuwn cases or A ML \\·ith or 
\\ ithuut trc;Jtment including relapsed case.'-' \vcrc also 
1wt included 
rahlt·-1: I~ ( 'la~~_l_lratiu~~- of .-\'1~, 
\hc'i<>ble<'l" k<>kCI"'" "''""'"''" clillccc'"li,llc'cl -Mil---~ 
\1:-~·l<llll;io.;IIL IL'ukcnlld \\"ilhoulm<Jilll-dll''n !\11 I 
\l_n·l,lbb~lic kukemi~1 11 1\h malur~lliPn )vJ:::' · 11_1pn;.:l;lllul~u-pmmycklc~·-1c lcukl"llli:l \1) I 
• \1iLT<l!:;i"<lllllial· ~~u-i<lll: \1)-l"ltlllhlll<lLylic IL·ul--.cmi:l \1--1 
• \\'llh hum· m:1rrtl\\ Cl'~lnop]llli.l :-,1--lhl ~~ 
\l,,il,ll"\ lie Lcul--.cnwt !\1:' 
p,,,,rJy dlilcrecnll.llCd 'vl:'i:1 
[)illc:i'Cnliatcd M5b I 
I n th,-,,kllh-mla !\1(1 
~1>·__s_:t!·<lll:<_lllLisl_~L Lcukc~-· __ !\-17 
Based on this. a told] or l\6 suhjech with 
llC\\·ly diagno~ed untreated denovc AM L were 
inl"ludcd in the study. It included paticnb o!' all age 
gnHtps and both -.;c\.c . .., 
The dic1gno...,i.s or .-\_\1L \\·a:-. established 
;JL'(mding to the stancLmi practicL'. and was h~hcd on 
]Kriphera! blood <md bone marrow morphology and 
cytochcmi-;rry. !mmunophcnotyping \\i.b done where 
con:--.idcrcll essential. I lcmatological lXlramctL-rs \\ere 
dom' on Coulter counter (model stak-:-,J_ 
Bone marrcl\\ <:bpirntion \\'<-lS done from 
pn<-;~cnm ilii.tC crc:-.t. A wrillcn consent w~1s taken 
!"rom patients or parents as appropriate. In C\Try Glse, 
h-S smcar_c; \\CI'L' nwdc: t\\0 of them \\ ith peripheral 
c;nll'<tr.c; were stained by· Leishman·~ stain. In addition 
Cullowing cytochemical stains were carried out on 
flcriphcral blood and bone marrow smears in each 
case: Sudan black!~ (SBB). periodic acid-Schiff 
(PAS). myelopcroxidase (Ml'O) and alpha naphthyl 
<!Cetak esterase (ANAE) by commercially provided 
kits !i·o111 Sigm<~ Diagnostic ac-cordin_g to 
m~lllll !':tcturcr · s illstrttctinllS. I nln1ttnophenotyping 
\\ :Lc; carried out in :-,omc pctticnb \Vith diagno~tic 
dilliculties and \\'tb performed hy 2 color flO\\ 
cytomctric anal_y'sis of hone marrow aspirak m 
peripheral blood specimens with a Becton Dickinson 
l\·lount<1in \'iew. Cal·if) L\C Scan instrument. Arter 
nlOllUnuclcacr cell enrichment by centrifugation O\'cr 
J !i.c;tnpaquc-1077 (Sigm<L St. Louis Vlo), samples 
\\ C1"C :--.tudicd for sudi1cc c1111igen cxpre:'ision u.sing a 
panL·l of 15 monoclonal antibodies supplied by 
(Ike ton Dickinson, San Jose, Calif and Dako 
!kn111;1rk). 
All the c<lScs were re\'icwed by first and 
third author independently. On the basis of 
morphology. cytochemistry and imtnunophenntyping, 
27 
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AML was elassiried into its various subtypes. (IV10-
M7) using FAH criteria. (Tablc-l)s cl-hc p1-escnce or 
absence of Aucr rod in each bone marrow film was 
also noted. 
RESULTS 
Qj' ]](--, CaSeS. 70 \\CrL' lllJlC.<; and 40 \\TI"L' felllalcs 
with male to female ratio 1.5: l. The mean age w:Jc; 32 
years (range 6 months RS years). 21 cases were up 
to the age of l5ycar~ comprising or 17 !lla\cs and 4 
female~ nnd their ag~..· range:~ between 6 month_..,_ 1) 
yem:>. Their hacmatolugical parameters arc gin::n in 
table :Z. The CHC shmYed a \\'ide range of variation in 
hemoglobin concentration and platelets ranging from 
~ubnormal to normal. Their Ltukocyte count ;_Jlso 
shm\ed vamttion from leucorenia t(l hyper 
leukocytosis. 
In our study. \\'e found AML (M4 FAB 
suhtypt,;s) to be the C"(lllll110ncst comrrising •-J.:z out of 
ll (J of' total cases (36.15%). This abo included 6 
C<.lse:--. of M4 Eo variant. The frequency of various 
AML subtypes according to FAR classification is 
given in Figure 1. 
Figure 1: French -American-British (I A. B) Sub 
types in 116 cases of A\1 L 
The cases were further dividc:d in adult and 
children group. Both groups- ren:alcd M4 as <l most 
common FAB type follO\\"ed by M2. Relative 
frequencies of V<JriOUS S-Ubtypes !(lr adults and 
children arc illustrated in Table 3. 
Aucr rods were present in 36.:2. {;..q 42 cases). 
They \\-'ere more common in \-13 subtype (9/12. 75~/[)) 
followed hy M2 (I X;35, 51 A'X,), M4 I \2;42, 2X 5%), 
Ml (2/10, 20%) and .\15 (L .. 7, 14.2(.%).Thc number of 
Aucr rods per cell was consistently grcate1 in lvB 
subtype. No Auer rods were observed in the ~·!() or 
M6 subtype. 
Tahle-2: Haematological parameter~ in A!VIL 
patients (n ~ 116) 
------r\t-e:ln ----R;~' 
1 !cmol.!.ltlbin ( "'nlidl) ~j·-- :::'.2"'i-l-4. 
Wl1itc Cell Coun1 ( j(fil 6:\.JlJ ll.(l---197 4 
PLllekl count ( 109/l) 4s~ I0-27o:o 
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Table 3: FAB distribution of AML according to 
a~e 2roup (n~ 116) 
Fab Group < 15 Years n 1X) > 15 Years n o/o 
MO 05 (23X) 04 (4.2) 
Ml 01 (4.7) 09 (9.4) 
M2 06 (28.5) 29(305) 
M3 00 (0) 12 ( 12.6) 
~ 07 (33.3) 35 (36.8) 
· M5 a 00 (0) 04(4.2) 
M5b 01 (4.7) 02 (2.\) 
M6 0 I (4.7) 00 (0) 
M7 
·--~-
00 (0) 00 (0) 
Total 21 (\00) 
DISCUSSION 
The FAB distribution of AML has been 
extensively studied in the past decades at national 
and international levels. 9' 12 -1'J In table 4 the adult 
results are compared with other series using fAB 
system. Most published data indicate the 
predominance of M2 as a most common subtvpc_'J l-+-
11''1x Occurrence of this subtype is also co;lllll<;n after 
primary malignancy? 1 However, two studies from 
Saudi Kingdom reported predominance of M4 and 
MS ~ubtypcs. L\.1? Nakasc et a[ showed AML-M4 as 
common subtype in Australian population compared 
to Japanese, where AML-M2 is common.11 Present 
study also confirms M4 as the most common type 
followed by M2. This is in concordance with the 
previously published results from our institution by 
With the introduction during the late 1960s and Kakepoto ct ai.
1
'J 
1970s of increasingly effective therapy for acute Many of the differences in AML ~ubtypcs 
leukemias, it became necessary to determine may be due to the subjectivity of morphologic 
subgroups, which might require different treatment diagnosis together with variable nature of acute 
approaches. In 1976 F AB system 4 of classification myeloid leukemia subtypes, with no real 
\vas introduced, which was subsequently revised at demarcation. Some genetic factors may be 
various times to improve concordancc. 5· 1'· 7 This responsible for a particular FAB subtype of AMLin 
system provided structured criteria for the diagnosis our population. Secondly most studies at national 
of various sub types of AML and is based mainly on level have small number of patients and probablv 
morphological and cytochemical features; for some \vith underutilization of cytochemical .'\tain;. 
of the categories, immunophenotyping is necessary. 1L'J Moreover these .<>tudies were not subjected to 
Since than it has been \videly adopted nationally and immunophcnotyping that may be because of error in 
internationally for classification of acute Ieukemlas, diagnosis. The other reason for this di,.crcpancy may 
although ambiguities still give rise to confu::;ion and it be patients of different ethnic group and/or 
has been the subject of recent criticism. 111 So. in 1997 geographical variation. 
a revised WHO ~lassification of AML was Published Auer rods were seen in 36 1% of cases with 
which included cytogenetic studie~ as wclJ. 11 highest frequency in M3. Spence ct a[ 13 reported 
However this classification is not practiced \Videly at Aucr rods in 40.6(% of cases in their series. These 
national level because of financial constraint.<;. The results are consit>tent with present study. 
clinical and biological significance is also claimed for Male to female ratio in present study is 
this sy~tcm which accounts for distinct prognostic 1 .5:1, which is in concordance with national and 
· t · I t d. 141(,172? differences for various subtypes and their close m ernattona s u tes. - · · - The mean age (32 
association w·ith chromosomal abnormalities. years) at presentation seems to be lower than the 
Although FAB propo~ab may be considered over expected mean age reported in western countries 
simplification, but they do serve to provide the where AML peaks in incidence after the 6(11 decade of 
guidelines for both hematologists and non specialists life.
23 
HO\vever, this is similar to mean age reported 








classification of these diseases. It is for these reasons The difference of mean age between present study 
that FAB is still favourite and popular among and western studies is probably due to different 
Pakistani hematologists. geographical distribution. 
Table 4: FAB Classification of AMLin various centers in adults 
Author/ Year/ No of Cases Moo;;, Ml'X, M2% M3(X, M4'Yo MS% M6'X. M7% 
Swirsky et al '1986 (U.K) n• 619 00 30 25 5 23 \3 2.4 00 
Spence el a! · 1988 (KSA) n 121 t.7 t.7 14.9 8.3 57.8 13.2 \.7 ()() 
Raina eta\ r:r\990 (Libya) n 54 00 7 57 15 \3 4 4 00 
Hassan eta!" 1993 (Pak) n 62 \.6 22.5 32.2 9.1 22.5 8.6 1.6 1.6 
Chaudry ct al"'1993 (Pak) n 54 00 13 44.4 11.1 24 3.7 3.7 00 
llarakat1 ct al ' 1998 (KSA) n 52 00 2 4 17 40 33 00 04 
Khaltd1 ct a\ " 1998 (USA) n·-78 8.9 19.2 27.0 9.0 20.5 11.5 2.6 1.3 
Kakeporo et al 2002 (Pak ) n 74 00 8.1 16 15 46 9.5 00 2.7 
Arber et al 2003 (USA) n ?55 7.0 19.2 28.67 8.7 26.7 4.8 2.5 2.4 
Present Study n 95 1.2 9.4 30.5 12.6 36.8 6.3 00 00 
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CONCLUSION 
In conclu~ion the most common type observed m our 
study wa~ Acute Myelornonocytic Leukemia (M4) 
ftJIIowcd by Acute \llyelob!astic Leukemia with 
111aturation (M2). Although demographic features is 
not the aim of our study but this is in accordance with 
o!hcr n<ttional studies. 
:\ multi-imtitutional study with large sample size 
!i-nm nthcr urcas of Pakistan is needed to confirm our 
J'indings. It IS de:;irable that more than one 
experienced observer should examine the material 
before <J final diagnosis i:; made. A full range of 
cytochemical stains ts essential with 
imnumophenotyping studies where appropriate for 
proper identification of the acute leukemias. 
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